In the TCGA HCC cohort, the Kaplan–Meier curves, along with the log‐rank test, demonstrated significant stratification of patients based on survival differences in XPO1, RPRD1B and RAN (Figure 5C). This evidence concerns the gene RAN and hepatocellular carcinoma.